New Ask Claude or ChatGPT about any stock, using Bullpen. Bullpen in Claude or ChatGPT. 7 days free

Friday, November 13, 2026

Back to the front page

The Spy Who Shagged The Market

Nvidia’s leadership scandal puts its AI-market role under scrutiny, with comparisons to AIG’s pre-GFC liquidity influence.

From X

DOMO Capital Management, LLC on X

Fantastic quarter from $ALTO - massive beat. 45Z credits continue to expand. Columbia now at $0.30 / gallon! Looks like a run rate of >$7M a quarter now. Management confirmed they expect exports to Europe to resume in 2027 - a large reason being the depreciation of the Brazilian Real post Brazilian elections... ALTO Adjusted EBITDA was pretty stunning. Despite lower crush margins they essentially matched Q3 2026. They can now produce profitable quarters, quarter after quarter, even if crush margins are low. The company paid off another $6.5M in debt and has now paid off $26.5M YTD on a loan that has a 10% interest rate. Sounds like Pekin will be at either a $0.30 or $0.40 / gallon run-rate in 2027 as they have also been able to partner with farmers to purchase low carbon corn. Some of these additional profits will be shared with the farmer. Sounds like we'll also get an update soon on Pekin CO2 monetization opportunities to get the 45Q utilization credit on currently vented CO2 from the wet mills. Columbia is also having the extra CO2 storage tank installed in Q4. Management has yet to guide the additional millions the Columbia plant will earn in 2027 due to this - would expect an update on the next call. Fantastic earnings, fantastic call... stock should be much higher. Management additionally confirmed that zero shares were sold using the ATM and that it wasn't contemplated at all even when the shares were in the $5-$6 range and certainly not now. This should be of zero concern at these levels.

QXO Inc Earnings Update: Q3 2026

QXO's Q3 sales rose 79% to $4.9 billion after TopBuild and Kodiak acquisitions, while acquisition debt lifted interest expense to $163…

IEH Corporation: Research Note

IEH Corporation posted Q2 revenue growth of 51% to $10.7 million and a record $56 million backlog, led by defense and medical demand.

Qure Anniversary Update

UniQure’s Huntington’s disease BLA has a May 1, 2027 priority-review date, with an FDA advisory committee expected in late first quarter.

Big Short: Fidelity & Guaranty

F&G’s main insurer held $66.5 billion of assets against $1.38 billion of statutory capital, while private credit, reinsurance dependence…

Publications we follow

Every publication on this site, hand-picked.

130 publications

Newsletters 110

X accounts we follow

Every account on this site, hand-picked.

91 accounts

Investor letters we follow

376 firms

Sectors

Ordered by how often our editor reaches for them.